| Feature | Specification |
|---|---|
| Unit Size | 1 vial (10 doses) |
| Specificity | Carbonic Anhydrase IX |
Loading...
In cancer, hypoxia occurs in tumors as a result of the poor ability of their disorganized vascular networks to deliver blood borne oxygen. IVISense Hypoxia CA IX 680 fluorescent imaging probe detects the tumor cell surface expression of carbonic anhydrase 9 (CA IX) protein, which increases in hypoxic regions within many tumors, especially in cervical, colorectal, non-small cell lung tumors. Pairing IVISense Hypoxia CA IX 680 agent with optical fluorescent imaging technology allows you to image and quantitate tumor sub-regions undergoing hypoxia-related changes, non-invasively and in vivo.
| Brand |
IVISense
|
|---|---|
| Fluorescent Agent Type |
Targeted
|
| Imaging Modality |
Fluorescence
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Specificity |
Carbonic Anhydrase IX
|
| Storage Conditions |
+2 to +8 °C
|
| Therapeutic Area |
Angiogenesis
Arthritis
Oncology
|
| Unit Size |
1 vial (10 doses)
|
| Wave Length |
680 nm
|
Are you looking for resources, click on the resource type to explore further.
Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into...
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and...
We are here to answer your questions.